Inoviq Ltd (AU:IIQ) has released an update.
INOVIQ Ltd has teamed up with Promega Corporation to enhance exosome research, offering Promega’s global customers access to INOVIQ’s EXO-NET exosome capture tool for advanced biomarker discovery and diagnostics. This global supply and distribution agreement, building on a successful co-marketing partnership, aims to revolutionize the field of exosome diagnostics and therapy by combining EXO-NET’s capture efficiency with Promega’s nucleic acid extraction expertise.
For further insights into AU:IIQ stock, check out TipRanks’ Stock Analysis page.
